Homegrown COVID-19 pill gets regulatory approval
By Wang Xiaoyu |
chinadaily.com.cn |
Updated: 2022-07-25 19:48
Share
Share - WeChat
China's top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.
Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.
The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.
- Parade brings service members' dreams alive
- China activates Ningxia-Hunan power line
- Autonomous taxis drive Hainan's smart tourism
- Shenyang exhibit showcases historical justice
- Program aims to popularize awareness of disability prevention countrywide
- Death toll rises to 5 amid heavy rains in Inner Mongolia's Ordos
